| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GILD | Common Stock | Options Exercise | +3,025 | +2.9% | 108,643 | 10 Mar 2023 | Direct | F1 | ||
| transaction | GILD | Common Stock | Options Exercise | +7,394 | +6.8% | 116,037 | 10 Mar 2023 | Direct | F1 | ||
| transaction | GILD | Common Stock | Tax liability | $385,496 | -4,849 | -4.2% | $79.50 | 111,188 | 10 Mar 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GILD | Restricted Stock Unit | Options Exercise | -3,025 | -7.1% | 39,644 | 10 Mar 2023 | Common Stock | 3,025 | Direct | F1, F2 | |||
| transaction | GILD | Restricted Stock Unit | Options Exercise | -7,394 | -19% | 32,250 | 10 Mar 2023 | Common Stock | 7,394 | Direct | F1, F3 | |||
| transaction | GILD | Restricted Stock Unit | Award | +16,350 | +51% | 48,600 | 10 Mar 2023 | Common Stock | 16,350 | Direct | F1, F3 | |||
| transaction | GILD | Non-qualified Stock Option (Right to Buy) | Award | $0 | +74,565 | $0.000000 | 74,565 | 10 Mar 2023 | Common Stock | 74,565 | $79.50 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| F2 | The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested. |
| F3 | The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| F4 | The options have a four year vesting schedule. 25% vest on the first anniversary date of the date grant. The balance will vest 6.25% quarterly thereafter until fully vested. |